AlphaStocks
4.8
Weak

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Health Care / Pharmaceuticals

S&P SmallCap 600

$33.25

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

#629out of 1127 in Health Care

Is COLLEGIUM PHARMACEUTICAL, INC a Good Investment in 2026?

COLLEGIUM PHARMACEUTICAL, INC (COLL) scores 4.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Greenblatt Magic Formula model rates COLLEGIUM PHARMACEUTICAL, INC as Strong (Top 25% (rank 14%)). However, the Graham model rates it Caution — 38% above fair value. COLLEGIUM PHARMACEUTICAL, INC currently trades below its estimated fair value of $44, suggesting potential upside. COLLEGIUM PHARMACEUTICAL, INC ranks #629 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E21.0ROE10.1Market Cap1.3T

Estimated Fair Value

$44.4325% below

Fair value above market price. P/E of 21x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

38% above fair value

Lynch

Neutral

PEG 0.9 · Fast Grower

Greenblatt

Strong

Top 25% (rank 14%)

Frequently Asked Questions

Is COLLEGIUM PHARMACEUTICAL, INC (COLL) a good investment?
Based on AlphaStocks' composite analysis, COLLEGIUM PHARMACEUTICAL, INC (COLL) scores 4.8 out of 10, earning a Weak rating. This score is below average, suggesting caution. Fair value above market price. P/E of 21x is moderate for this quality level.
What is COLLEGIUM PHARMACEUTICAL, INC's Piotroski F-Score?
COLLEGIUM PHARMACEUTICAL, INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is COLL overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $44, COLL appears undervalued. The stock currently trades 25% below its estimated fair value. Fair value above market price. P/E of 21x is moderate for this quality level.
How does COLL compare to other Health Care stocks?
COLLEGIUM PHARMACEUTICAL, INC ranks #629 out of 1127 stocks in the Health Care sector, placing it in the top 56% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about COLL?
AlphaStocks evaluates COLL using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 4.8/10.

Similar Stocks

PARRFTIAZN

Compare COLL with

COLL vs PARRCOLL vs FTICOLL vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer